A new pill to treat advanced hormone sensitive prostate cancer that could benefit just over 40,000 people has been ...

Rucaparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy [ID5100] Draft guidance Technology appraisal ...

During the pre-election period, 22 May to 5 July 2024, restrictions imposed on public bodies meant NICE was prevented from publicising its work. We did still continue developing useful and useable ...

A digital technology that will help healthcare professionals provide a quicker diagnosis to people with attention deficit hyperactivity disorder (ADHD) can be used by the NHS, NICE has said in draft ...

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

Further information Decision makers have concluded that this technology will not progress as a potential technology appraisal (TA) or a highly specialised technology (HST) as is not a new active ...

You should read both the consultation document and the accompanying evidence (see the committee papers) before making any comments. You must make your comments ...

A list of downloadable documents created during development.

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...